Sign in
4

Changes in Ownership

Insight Molecular Diagnostics Inc. Filed Acc 0001493152-23-001946

Options or other derivatives

  • Interim CEO acquired 257,485 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Riggs Josh Interim CEO 2023-01-17 Grant or award · Option to Purchase Common Stock +257,485 257,485 D
Loading xslF345X03/ownership.xml…